Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Melanoma

NCT00004184 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: monoclonal antibody 4B5 anti-idiotype vaccine
BIOLOGICAL: sargramostim
DRUG: alum adjuvant

Sponsor

University of Alabama at Birmingham

Collaborators

[object Object]